公司资料
GE HealthCare Technologies Inc. 股价、新闻与催化剂
- 股票代码:
- GEHC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
63.98 USD (-2.13%)
收盘价
最后更新: 2026年10月1日
28.2B USD
市值
股价为何变动
截至 2026年10月1日，GEHC 下跌 2.13%，收于 $63.98。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Global Medical Technology Company
GE HealthCare provides medical imaging, pharmaceutical diagnostics, patient monitoring, ultrasound, and healthcare software. Its products and services support diagnosis, therapy planning, clinical decision-making, and longitudinal patient management.
Advanced Imaging Solutions
Advanced Imaging Solutions includes magnetic resonance, computed tomography, molecular imaging, ultrasound, image-guided therapy, and advanced visualization. The segment combines large installed equipment with software upgrades, service contracts, and procedure-driven utilization.
Pharmaceutical Diagnostics
Pharmaceutical Diagnostics supplies contrast media and molecular imaging agents used with imaging systems. This business links diagnostic pharmaceuticals with the company's scanner installed base and provides recurring revenue tied to patient procedures.
Patient Care Solutions
Patient Care Solutions includes monitoring, maternal and infant care, anesthesia delivery, diagnostic cardiology, and related technologies. These products are used across hospitals, intensive care units, operating rooms, and ambulatory settings.
AI, Cloud, and Precision Care
GE HealthCare integrates artificial intelligence, cloud software, and workflow tools into imaging and clinical systems. Its strategy is to help clinicians interpret data, automate repetitive tasks, personalize diagnosis and therapy, and connect information across care settings.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。